Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.34x
EV / EBIT 16x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.319
EBIT 1 3.821
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 26/8/25
1INR in Million2INR
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 984K
-157.29x13.04x-177.54x-.--% 37.52B
20.63x1.97x11.34x0.98% 24.34B
17.26x1.34x7.62x5.12% 7.33B
315.74x - - - 4.84B
48.53x8.77x30.76x1.02% 3.05B
-31.16x - - -.--% 1.81B
31.67x1.57x11.95x1.62% 1.78B
-17.67x - - - 1.75B
12.66x1.31x5.13x5.99% 1.74B
Average 26.71x 4.67x -18.46x 2.1% 8.42B
Weighted average by Cap. -42.84x 7.64x -81.91x 1%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited